Guru Ownership Trend
Guru Analysis for Caris Life Sciences, Inc. (CAI)
Caris Life Sciences, Inc. (CAI), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 7 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $69.34 M.
Top institutional holders include Stanley Druckenmiller and Steven Cohen.
Institutional sentiment is currently Bullish. This is evidenced by a $19.42 M net inflow during the quarter.
Recent activity highlights Joel Greenblatt who dramatically increased their stake. Conversely, Steven Cohen reduced exposure by 50.8%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Caris Life Sciences, Inc. (CAI)
Major holders include Stanley Druckenmiller ($33.87 M), Steven Cohen ($16.42 M), Joel Greenblatt ($13.31 M). According to the latest reported data, 7 tracked investment managers collectively hold approximately 4.15 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $19.42 M, with 5 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 1 fully exited CAI. The total reported sell value was $29.42 M.
Yes, 3 managers opened new positions in CAI, and 2 increased their existing holdings. The total reported buy value was $48.84 M.
